The One Number That Decides Whether Your Serum Actually Works

She left it on the bathroom counter with a sticky note. "Try it. I dare you."

I'm Evan Carter. I'm from Elmhurst, Illinois. I have a brindle French Bulldog named Dutch and a well-documented distrust of any product that costs $80, smells vaguely floral, and makes promises without citing a single source. I'd watched the skincare industry sell my girlfriend increasingly expensive hope for years — serums with beautiful packaging, ingredient names I couldn't verify, and concentrations that were never disclosed.

So I grabbed the bottle. I read the label. I opened three browser tabs on the active ingredient and got ready to build a careful, evidence-based case for why nothing on her counter was actually doing anything.

Six weeks later, I still hadn't given the bottle back.

Not because the marketing won me over. Because the research was more persuasive than anything printed on the box — and when I dug one layer deeper, I found something that made me genuinely angry.

Most brands selling copper peptide serums aren't selling the dose the research studied. They're selling a fraction of it. They've been doing it for years. And the labeling laws in most markets mean their customers have no way to know.

Discovered in 1973. Documented for fifty years. Almost never dosed correctly.

The compound is called GHK-Cu. Copper tripeptide-1. A biochemist named Loren Pickart first isolated it from human blood plasma in 1973 — over fifty years ago — and it's accumulated one of the most substantial research records of any topical cosmetic ingredient in existence. More than seventy peer-reviewed papers. Documented effects on collagen synthesis, elastin production, fibroblast activation, and structural skin repair at the cellular level.

This isn't a new ingredient with exciting early data. It's a fifty-year-old ingredient with a serious body of evidence — the kind that most skincare actives will never accumulate.

GHK-Cu (Copper Tripeptide-1) First isolated in 1973. 70+ peer-reviewed studies. Shown to signal the fibroblasts responsible for collagen and elastin production. Research-backed concentration: 1–2% for meaningful structural effect.

So why hadn't it worked for me before? Why hadn't it worked for almost anyone I knew who'd ever tried a copper peptide serum?

The answer was one number that almost no brand discloses.

The industry discovered the ingredient. Then quietly defanged it.

I spent three weeks going through the published literature. Every study that documented meaningful collagen signaling — the ones with measurable structural results — was working in the 1–2% concentration range. That's the dose the research supports. Below that window, you may get some surface hydration. You are not getting structural change.

Then I went and looked at every copper peptide serum I could find at retail.

Most were formulated at 0.25%. A few mid-range products at 0.5%. Some "professional" formulas advertised up to 1% — but at the lower bound of the therapeutic range, where results are inconsistent at best. Virtually nothing at the full 2%.

The reason is straightforward: copper peptide raw material costs approximately 8× more per unit at 2% concentration than at 0.25%. The formula is significantly more expensive to produce. The margin narrows.

And here is the part that made me angry: in most markets, brands are not legally required to disclose active-ingredient concentration. They only need to list the ingredient name. So a product at 0.25% and a product at 2% can both legally be sold as a "copper peptide serum." Both list GHK-Cu on the label. Both can charge $70 or $80. Only one is dosed to do anything structural.

Your previous serum almost certainly had the ingredient. It just didn't have enough of it. That isn't a personal failing. It's an industry choosing margin over formula, hiding behind labeling that doesn't require them to show their work.